Life Healthcare Advances Strategic Growth Agenda with Capacity Expansion and Improved Operational Performance
Life Healthcare Group has reported encouraging progress in the execution of its long-term growth strategy, delivering improved operational momentum and continued investment in healthcare infrastructure during the six months ended March 31, 2026. The Group’s unaudited interim results highlight its commitment to strengthening healthcare access, enhancing operational efficiency, and expanding capacity to meet evolving patient needs across its markets.
Despite facing a challenging operating environment during the first half of the financial year, Life Healthcare remained focused on implementing its Grow, Drive and Optimise strategy. Through disciplined execution, targeted investments, and ongoing operational improvements, the Group continued to build a foundation for sustainable growth while maintaining a strong financial position.
Strategic Investments Support Healthcare Access
A key component of Life Healthcare’s strategy is ensuring that healthcare infrastructure and service capacity are aligned with patient demand. During the reporting period, the Group made significant progress in expanding its healthcare footprint and increasing access to specialized medical services.
One of the most notable developments was the commencement of construction on the new 140-bed Life Paarl Valley Hospital. The facility is expected to strengthen healthcare delivery in a growing region and improve access to high-quality medical care for local communities.
In addition to this greenfield project, Life Healthcare continued to invest in several brownfield expansion initiatives across its existing network. These projects include the addition of acute-care beds and specialized treatment facilities designed to accommodate changing disease patterns and increasing demand for complex medical services. By expanding existing facilities, the Group aims to improve patient access while maximizing the efficiency of its current healthcare infrastructure.
The company also continued to strengthen its complementary healthcare services portfolio. Growth initiatives focused on high-demand areas such as acute rehabilitation, advanced diagnostic imaging, and renal dialysis services. These offerings play an increasingly important role in supporting integrated patient care pathways and addressing the growing need for specialized healthcare solutions.
Further progress was made in expanding the Group’s cyclotron infrastructure, which supports advanced nuclear medicine and diagnostic imaging capabilities. Investments in this area are expected to enhance diagnostic accuracy, improve patient outcomes, and reinforce Life Healthcare’s position as a provider of innovative healthcare services.
Asset Optimization Remains a Strategic Priority
Life Healthcare continued to advance its asset optimization program during the reporting period. The initiative, which remains under close Board oversight, is focused on ensuring that the Group’s portfolio remains aligned with long-term strategic objectives.
The optimization program seeks to improve operational efficiency, strengthen financial returns, and enhance the overall performance of the business while maintaining high standards of patient care. Management indicated that progress is being made in evaluating opportunities to improve asset utilization and streamline operations across the healthcare network.
By carefully balancing efficiency improvements with patient-centered care delivery, the Group aims to create a stronger and more sustainable operating model capable of supporting future growth opportunities.
Financial Performance Reflects Operational Resilience
Despite external challenges that affected activity levels during the first half of the year, Life Healthcare delivered solid financial results. Group revenue increased by 2.4% year-over-year to R12.4 billion, reflecting resilience across its healthcare operations and continued demand for its services.
Normalised EBITDA increased by 5.2% to R2.0 billion, demonstrating the benefits of ongoing cost management initiatives and operational efficiencies. Operating profit before non-trading items rose by 8.4%, highlighting the Group’s ability to improve profitability even within a constrained operating environment.
Normalised earnings per share also increased by 8.4%, reaching 53.1 cents per share. This performance underscores management’s focus on driving earnings growth while maintaining disciplined operational execution.
The Board further demonstrated confidence in the Group’s financial strength by approving an interim cash dividend of 23.0 cents per share, representing a 9.5% increase compared with the prior period.
Stronger Performance in the Second Quarter
While the first half of the financial year was affected by external factors, including disruptions related to healthcare funders, operational performance improved significantly during the second quarter.
Occupancy levels across the Group’s facilities recovered steadily and exceeded 70% during the second quarter, signaling a positive improvement in patient activity and healthcare service utilization. This recovery reflects both the resilience of underlying healthcare demand and the effectiveness of management’s operational initiatives.
For the six-month reporting period, acute hospital occupancies on a like-for-like basis reached 67.0%. Intensive Care Unit (ICU) utilization remained particularly strong at 82.0%, reflecting ongoing demand for critical care services.
Management noted that the second-quarter recovery provides encouraging signs for future performance as patient volumes continue to normalize and healthcare activity levels improve.
The Group’s admissions profile remained broadly consistent with recent trends. Medical admissions accounted for 54% of total admissions, while surgical admissions represented 46%. This balance reflects ongoing demand for medical treatment and chronic disease management services across the healthcare system.
Complementary healthcare services continued to contribute meaningfully to growth. Strong demand for mental health services, diagnostic imaging, and renal dialysis treatments supported revenue generation and reinforced the strategic importance of these expanding service lines.
Cost Discipline Enhances Profitability
Life Healthcare’s focus on operational excellence and disciplined cost management contributed to an improvement in EBITDA margins during the reporting period.
The company implemented a range of initiatives aimed at improving productivity, controlling expenses, and enhancing resource utilization across its operations. These measures helped offset external pressures while supporting profitability growth.
Management emphasized that efficiency improvements remain a central component of the Group’s strategy. By continuously evaluating operational processes and identifying opportunities for optimization, Life Healthcare seeks to improve earnings quality and strengthen financial performance over the long term.
Strong Balance Sheet Supports Growth Investments
The Group maintained a healthy financial position throughout the reporting period, providing flexibility to continue investing in strategic growth initiatives.
Net debt to normalized EBITDA stood at 0.93 times, reflecting a conservative leverage profile and a strong balance sheet. This financial strength enables Life Healthcare to pursue expansion opportunities while preserving financial stability.
Capital expenditure during the six-month period totaled R722 million. Investments were primarily directed toward infrastructure development, capacity expansion projects, and service diversification initiatives that align with the Group’s long-term growth objectives.
The company’s disciplined approach to capital allocation ensures that investment decisions support sustainable growth while generating value for shareholders and improving patient access to healthcare services.
Leadership Confident in Long-Term Strategy
Commenting on the interim results, Chief Executive Officer Peter Wharton-Hood highlighted the Group’s continued strategic progress and improving operational performance.
According to Wharton-Hood, Life Healthcare remains focused on expanding capacity in areas of greatest patient need, improving utilization rates across its network, and advancing optimization initiatives that strengthen long-term returns. He noted that the recovery in healthcare activity during the second quarter demonstrates the resilience of the business and supports confidence in the Group’s growth strategy.
Management believes the company is well-positioned to capitalize on future opportunities while continuing to deliver high-quality healthcare services across its markets.
Outlook for the Remainder of FY2026
Looking ahead, Life Healthcare’s priorities remain centered on restoring activity levels, improving facility utilization, and accelerating revenue growth.
The Group will continue emphasizing productivity improvements and cost discipline to support margin expansion. Management is targeting approximately R400 million in cost savings over a three-year period as part of its broader efficiency strategy.
Capital allocation will remain focused on executing the current expansion pipeline, supporting strategic growth projects, and maintaining balance sheet flexibility for future investment opportunities.
For the remainder of the 2026 financial year, Life Healthcare expects occupancies to average approximately 68% and anticipates revenue growth of around 2.0%. Management believes that continued progress on strategic projects, combined with ongoing optimization initiatives and improving operational momentum, will support sustainable performance and position the Group for long-term value creation
About
The Group’s priorities for the remainder of the financial year are clear: restoring activity levels, improving utilisation and driving revenue growth, while maintaining a strong focus on productivity and cost discipline to support margin expansion including cost savings of R400 million over 3 years.
Capital allocation will remain disciplined, with continued investment in the current expansion pipeline, alongside preserving balance sheet strength and flexibility for future opportunities.
The Group expects occupancies of approximately 68% and revenue growth of 2.0% for the remainder of FY2026, supported by continued strategic project delivery and further progress in optimisation initiatives.
